Latest Global Cord Blood Corporation News & Updates

See the latest news and media coverage for GCBC. We track all announcements, press releases, and industry mentions in real time, all in one place.

Global Cord Blood Corporation (GCBC)

Cord blood banking and life sciences company in provisional liquidation

globalcordbloodcorporation.com

Last updated Today

Latest news about Global Cord Blood Corporation (GCBC)

In short: GCBC sought court sanction of liquidators' fees while its joint liquidators sold their Cordlife Group stake.

Company announcements

11 February 2025 GCBC

GCBC seeks court sanction of second fee period

JPLs request dispensation of EGM due to disputed register; shareholders may raise concerns by 7 March 2025.

9 August 2024 GCBC

GCBC updates shareholders on JPL remuneration hearing date

The court approved remuneration terms and adjourned fee approval hearing to 9 October 2024.

29 May 2024 GCBC

GCBC seeks court approval for liquidators' fees

The Joint Provisional Liquidators filed a summons for approval of US$10.3M in fees and disbursements for the period to Sep 2023.

26 September 2022 GCBC

GCBC appoints joint provisional liquidators and suspends board powers

A Cayman Court order grants liquidators authority to manage operations and investigate affairs starting September 22, 2022.

Media coverage

6 August 2024 Singapore Business Review

GCBC's joint liquidators sell full stake in Cordlife Group | Singapore Business Review

The joint liquidators of Global Cord Blood Corporation (GCBC) have disposed of their entire stake in the Cordlife Group.

11 June 2024 Business Wire

Rosen Law Firm Urges Global Cord Blood Corporation (NYSE: CO) (OTC: CORBF) Stockholders With Large Losses to Contact the Firm for Information About Their Rights

NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Global Cord Blood Corporation (NYSE: CO) (OTC: CORBF...

16 June 2022 PR Newswire

Global Cord Blood Corporation Announced Cellenkos Receives FDA Clearance of IND Application for CK0804 as Add on Therapy to Ruxolitinib for the Treatment of Myelofibrosis

/PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing,...

29 April 2022 Nasdaq

Blue Ocean Successfully Applied Injunction to Stop Global Cord Blood from Acquiring Cellenkos Following Cayman Islands Court Ruling

NEW YORK, May 13, 2022 /PRNewswire/ -- Blue Ocean Structure Investment Company Ltd. ("Blue Ocean"), a significant shareholder of Global Cord Blood Corporation (the "Company...

Never miss news about GCBC

Track GCBC and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.